Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COCKTAIL-DM: SWT and PRP for Erectile Dysfunction
NCT05525572Phase 2Terminated
- Sponsor
- University of Miami
- Start
- Feb 2024
- Primary completion
- Aug 2024
- Modality
- Adoptive Cell Transfer
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of autologous platelet-rich plasma in erectile dysfunction (ED), sponsored by University of Miami. Primary endpoints: Markers of Vasodilation at Month 6, Endothelial Function Markers at Month 6 and 2 more. Started Feb 2024; status: terminated.
02
Drugs
autologous platelet-rich plasma
03
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on NCT05525572.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05525572.